Nimenrix 44 mcg (Tetanus Toxoid KIT) 44 MCG

NIMENRIX 44 MCG is a vaccine kit designed to provide protection against tetanus. This intramuscular injection is manufactured by Pfizer Canada ULC and is suitable for individuals requiring immunization. Learn more about its uses and effects.

Strength

44 MCG

Pack Size

0.5ML/10X0.5ML

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NIMENRIX 44 MCG is primarily used for the prevention of tetanus, a serious bacterial infection. This vaccine is administered intramuscularly and is part of a broader immunization strategy to protect against tetanus. Individuals may receive this vaccine as part of their routine immunization schedule or in response to specific exposure risks.

Side Effects

Common effects of NIMENRIX 44 MCG may include mild soreness or redness at the injection site. Some individuals might experience temporary discomfort or swelling. These effects are generally mild and short-lived, indicating that the body is responding to the vaccine.

Precautions & Warnings

It is important to inform your healthcare provider about any allergies or medical conditions before receiving NIMENRIX 44 MCG. The vaccine should be stored and handled according to the manufacturer's guidelines to ensure its effectiveness. Always follow the advice of a healthcare professional regarding vaccination.

Avoid Interactions

NIMENRIX 44 MCG may interact with certain medications or other vaccines. It is advisable to discuss your current medications with a healthcare provider before receiving this vaccine. Additionally, avoid taking alcohol or other substances that may affect your immune response.

Frequently Asked Questions

NIMENRIX 44 MCG is used for the prevention of tetanus, a serious bacterial infection.

NIMENRIX 44 MCG is administered intramuscularly, typically in the upper arm or thigh.

Common effects may include mild soreness, redness, or swelling at the injection site.

Individuals with a history of severe allergic reactions to tetanus toxoid or any component of the vaccine should avoid receiving NIMENRIX 44 MCG.

It is important to consult a healthcare provider about any medications you are taking before receiving NIMENRIX 44 MCG.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.